Development of sertraline analogues as potential anti-ischemic stroke agents.

Autor: Chen X; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China., Liu HY; Department of Pharmaceutical Chemistry, Third Military Medical University, Chongqing, 400038, China., Niu SL; Department of Pharmaceutical Chemistry, Third Military Medical University, Chongqing, 400038, China., Zhou T; Department of Neurology, Xinqiao Hospital, Third Military Medical University, Chongqing, 400038, China., Yuan W; Department of Pharmaceutical Chemistry, Third Military Medical University, Chongqing, 400038, China., Zheng PF; Department of Pharmaceutical Chemistry, Third Military Medical University, Chongqing, 400038, China., Chen Q; Department of Neurology, Xinqiao Hospital, Third Military Medical University, Chongqing, 400038, China., Luo SL; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China; Medical College, Guangxi University, Nanning, 530004, China., Gu J; Department of Pharmaceutical Chemistry, Third Military Medical University, Chongqing, 400038, China. Electronic address: gujing_1020@126.com., Zhangsun DT; Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China. Electronic address: zhangsundt@163.com., Ouyang Q; Department of Pharmaceutical Chemistry, Third Military Medical University, Chongqing, 400038, China. Electronic address: ouyangq@tmmu.edu.cn.

Publikováno v: European journal of medicinal chemistry [Eur J Med Chem] 2023 Apr 05; Vol. 252, pp. 115273. Date of Electronic Publication: 2023 Mar 15.